Growing demand for automated nucleic acid extraction systems in hospitals & diagnostic centers is attributed to rising research initiatives, use of nucleic acid testing in molecular diagnostics, and high requirement for rapid and precise disease diagnosis.
NEWARK, DE / ACCESSWIRE / November 5, 2024 / The Automated Nucleic Acid Extraction Systems Market is set for remarkable growth. Revenue is projected to reach USD 10,117.7 million by 2034 from an estimated USD 4,643.3 million in 2024, growing at a robust CAGR of 8.1% over the forecast period. Demand for reliable, efficient, and high-quality nucleic acid extraction has surged, driven by advancements in molecular diagnostics for early detection and treatment of various genetic and infectious diseases.
With nucleic acid extraction playing a pivotal role in fields such as oncology, infectious disease control, and personalized medicine, automated systems ensure precision, reliability, and time efficiency in laboratory workflows. The ongoing pandemic has also underscored the importance of high-throughput diagnostic capabilities, further cementing the role of automation in healthcare. As diagnostics evolve toward enhanced precision, automated systems that offer repeatable, high-quality extractions are essential to streamline workflows in laboratories and research settings worldwide.
A key application of these systems lies in identifying disease markers, mutations, and RNA profiles that are critical for conditions such as cancer, genetic disorders, and infectious diseases. Automation minimizes contamination and increases yield, ensuring that labs can handle larger sample volumes with consistent results.
Growth Drivers and Opportunities
Laboratory automation is a primary driver in this market, enabling high-throughput processing with minimal human intervention. As diagnostics increasingly depend on molecular accuracy, automated systems are pivotal in ensuring sample integrity, reproducibility, and speed. Investment in nanotechnology research also opens new avenues for nucleic acid extraction systems, particularly in cutting-edge applications like nanopore sequencing and biosensors.
Furthermore, rising demand for personalized medicine has created opportunities for precision tools in diagnostics. Automated extraction systems are thus integral to supporting advanced healthcare solutions, as they ensure rapid and accurate sample preparation essential to individualized treatments.
Key Takeaways from Market Study
CAGR: Expected CAGR of 8.1% from 2024 to 2034.
Market Growth: Market size forecasted to grow from USD 4,643.3 million in 2024 to USD 10,117.7 million in 2034.
Segment Demand: High demand in oncology, genetic disorders, and infectious disease diagnostics.
Innovation in Nanotechnology: Growing investment in nanotechnology drives demand for high-quality automated extraction systems.
"The Automated Nucleic Acid Extraction Systems Market is poised for sustained growth, driven by the increasing reliance on molecular diagnostics across medical and research sectors. Automated systems play a critical role in ensuring sample consistency and diagnostic accuracy, especially in high-demand environments like hospitals and research institutions. "Says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Market's Prime Determinants of Growth, Trends, and Opportunities
Automation trends in laboratories and the ongoing push towards precision medicine are key growth determinants for the automated nucleic acid extraction systems market. Growing emphasis on early and accurate disease diagnosis fuels the adoption of these systems across diagnostic labs, research institutions, and hospitals. Advances in nanotechnology, biomarker discovery, and cancer diagnostics are key trends bolstering demand, as laboratories increasingly require standardized and automated solutions for nucleic acid extraction.
Regional Analytics of the Automated Nucleic Acid Extraction Systems Market (2024-2034):
Countries |
Value CAGR (2024 to 2034) |
China |
6.7% |
India |
7.1% |
United States |
1.7% |
South Korea |
5.4% |
Canada |
3.0% |
Spain |
3.6% |
Germany |
1.8% |
France |
2.6% |
Key Companies & Market Share Insights
Prominent players in the automated nucleic acid extraction systems market include Qiagen N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., PerkinElmer Inc., and Hamilton Company. These companies are investing in advanced research, technology development, and collaborations to gain a competitive edge. Their focus remains on improving system efficiency, speed, and compatibility with diverse laboratory setups.
Key Segments of Automated Nucleic Acid Extraction Systems Market
By Type:
In terms of type, the industry is divided into instruments, kits and consumables.
By End User:
In the terms of end user, the market is segmented into hospitals, diagnostic centres, forensic laboratories, pharmaceutical & biotechnology companies and academic research institutes.
By Regions:
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia and Middle East and Africa (MEA) have been covered in the report.
To Gain In-Depth Insights on Market, Browse Complete Report: https://www.futuremarketinsights.com/reports/automated-nucleic-acid-extraction-systems-market
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Have a Look at the Related Report from the Automated Nucleic Acid Extraction Systems Market:
The global sales of Medical Carts are estimated to be worth USD 1,136.9 million in 2024 and are anticipated to reach a value of USD 2,817.6 million by 2034. Sales are projected to rise at a CAGR of 9.5% over the forecast period between 2024 and 2034.
The global sales of teleradiology market is estimated to be worth USD 8,894.3 million in 2024 and anticipated to reach a value of USD 47,748.5 million by 2034.
The global sales of suture needles market are estimated to be worth USD 625.0 million in 2024 and anticipated to reach a value of USD 1,008.3 million by 2034.
The global sales of wearable healthcare devices market are estimated to be worth USD 19,163.1 million in 2024 and anticipated to reach a value of USD 43,327.4 million by 2034
The global sales of ultrasound conductivity gels market are estimated to be worth USD 325.9 million in 2024 and anticipated to reach a value of USD 690.7 million by 2034.
The global sales of contrast media injectors market is estimated to be worth USD 4,949 million in 2024 and anticipated to reach a value of USD 8,832.8 million by 2034.
The global sales of anaesthesia machines market is estimated to be worth USD 11,126.0 million in 2024 and anticipated to reach a value of USD 17,780.9 million by 2034.
The global sales of dermal fillers market are estimated to be worth USD 6,411.8 million in 2024 and anticipated to reach a value of USD 8,819.6 million by 2034.
The Acetaminophen-Opioid Combination market is estimated to be worth USD 3,144.1 million in 2024 and is projected to reach a value of USD 4,522.6 million by 2034
The cardiac rehabilitation market is estimated to reach USD 2,343.5 million in 2024. Revenue is estimated to increase at a CAGR of 4.6% between 2024 and 2034.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blogs | YouTube
SOURCE: Future Market Insights Inc.
View the original press release on accesswire.com
